nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allosterically activating SHP2 by oleanolic acid inhibits STAT3–Th17 axis for ameliorating colitis
|
Hu, Jinbo |
|
|
14 |
6 |
p. 2598-2612 |
artikel |
2 |
An emerging terpolymeric nanoparticle pore former as an internal recrystallization inhibitor of celecoxib in controlled release amorphous solid dispersion beads: Experimental studies and molecular dynamics analysis
|
Lugtu-Pe, Jamie Anne |
|
|
14 |
6 |
p. 2669-2684 |
artikel |
3 |
Author correction to ‘FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis’ [Acta Pharm Sin B 14 (2024) 1605–1623]
|
Huang, Zhifeng |
|
|
14 |
6 |
p. 2791-2793 |
artikel |
4 |
Author correction to ‘VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity’ [Acta Pharm Sin B 11 (2021) 420–433]
|
Shang, Pengzhao |
|
|
14 |
6 |
p. 2790 |
artikel |
5 |
Carrimycin inhibits coronavirus replication by decreasing the efficiency of programmed –1 ribosomal frameshifting through directly binding to the RNA pseudoknot of viral frameshift-stimulatory element
|
Li, Hongying |
|
|
14 |
6 |
p. 2567-2580 |
artikel |
6 |
Ciclopirox inhibits SARS-CoV-2 replication by promoting the degradation of the nucleocapsid protein
|
Wei, Xiafei |
|
|
14 |
6 |
p. 2505-2519 |
artikel |
7 |
Cisplatin-based miRNA delivery strategy inspired by the circCPNE1/miR-330-3p pathway for oral squamous cell carcinoma
|
Fan, Hua-yang |
|
|
14 |
6 |
p. 2748-2760 |
artikel |
8 |
Computer-aided molecular design and optimization of potent inhibitors disrupting APC‒Asef interaction
|
Wang, Xuefei |
|
|
14 |
6 |
p. 2631-2645 |
artikel |
9 |
Cover Story
|
|
|
|
14 |
6 |
p. xii |
artikel |
10 |
Di-PEGylated insulin: A long-acting insulin conjugate with superior safety in reducing hypoglycemic events
|
Zeng, Zhipeng |
|
|
14 |
6 |
p. 2761-2772 |
artikel |
11 |
Directly targeting BAX for drug discovery: Therapeutic opportunities and challenges
|
Zhang, Zhenwei |
|
|
14 |
6 |
p. 2378-2401 |
artikel |
12 |
Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches
|
Elzoghby, Ahmed O. |
|
|
14 |
6 |
p. 2475-2504 |
artikel |
13 |
Enhanced optical imaging and fluorescent labeling for visualizing drug molecules within living organisms
|
Sun, Ting |
|
|
14 |
6 |
p. 2428-2446 |
artikel |
14 |
Expanding the horizons of targeted protein degradation: A non-small molecule perspective
|
Huang, Xiaowei |
|
|
14 |
6 |
p. 2402-2427 |
artikel |
15 |
Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits
|
Xiao, Bo |
|
|
14 |
6 |
p. 2732-2747 |
artikel |
16 |
Genome mining of sulfonated lanthipeptides reveals unique cyclic peptide sulfotransferases
|
Wang, Meng |
|
|
14 |
6 |
p. 2773-2785 |
artikel |
17 |
(+)/(−)-Gerbeloid A, a pair of unprecedented coumarin-based polycyclic meroterpenoid enantiomers from Gerbera piloselloides: Structural elucidation, semi-synthesis, and lipid-lowering activity
|
Zhao, Chenxu |
|
|
14 |
6 |
p. 2657-2668 |
artikel |
18 |
Glucagon-like peptide-1 receptor agonists rescued diabetic vascular endothelial damage through suppression of aberrant STING signaling
|
He, Xuemin |
|
|
14 |
6 |
p. 2613-2630 |
artikel |
19 |
Idebenone alleviates doxorubicin-induced cardiotoxicity by stabilizing FSP1 to inhibit ferroptosis
|
Qiu, Hongliang |
|
|
14 |
6 |
p. 2581-2597 |
artikel |
20 |
Interferon-induced MXB protein restricts vimentin-dependent viral infection
|
Yi, Dongrong |
|
|
14 |
6 |
p. 2520-2536 |
artikel |
21 |
Nanoparticle drug delivery system for the treatment of brain tumors: Breaching the blood–brain barrier
|
Tang, Qiyu |
|
|
14 |
6 |
p. 2786-2789 |
artikel |
22 |
Nanotherapeutics targeting autophagy regulation for improved cancer therapy
|
Liu, Yunmeng |
|
|
14 |
6 |
p. 2447-2474 |
artikel |
23 |
Pharmacokinetic enhancement of oncolytic virus M1 by inhibiting JAK‒STAT pathway
|
Tan, Jingyi |
|
|
14 |
6 |
p. 2554-2566 |
artikel |
24 |
Precise nano-system-based drug delivery and synergistic therapy against androgen receptor-positive triple-negative breast cancer
|
Gao, Fangyan |
|
|
14 |
6 |
p. 2685-2697 |
artikel |
25 |
Repurposing disulfiram with CuET nanocrystals: Enhancing anti-pyroptotic effect through NLRP3 inflammasome inhibition for treating inflammatory bowel diseases
|
Xu, Xueming |
|
|
14 |
6 |
p. 2698-2715 |
artikel |
26 |
Spirohypertones A and B as potent antipsoriatics: Tumor necrosis factor-α inhibitors with unprecedented chemical architectures
|
Duan, Yulin |
|
|
14 |
6 |
p. 2646-2656 |
artikel |
27 |
Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy
|
Qin, Xiaojing |
|
|
14 |
6 |
p. 2361-2377 |
artikel |
28 |
Suppressing Wnt signaling of the blood‒tumor barrier to intensify drug delivery and inhibit lipogenesis of brain metastases
|
Tong, Yang |
|
|
14 |
6 |
p. 2716-2731 |
artikel |
29 |
Table of Contents
|
|
|
|
14 |
6 |
p. iii-xi |
artikel |
30 |
Transient induction of actin cytoskeletal remodeling associated with dedifferentiation, proliferation, and redifferentiation stimulates cardiac regeneration
|
Fu, Wenbin |
|
|
14 |
6 |
p. 2537-2553 |
artikel |